Sleep Apnea Diagnosis and Management With Wesper and Impilo

Impilo and Wesper work together to support sleep apnea diagnosis and management. Impilo's device integration brings Remote Patient Monitoring (RPM) data to providers, and Wesper's wireless biometric patches record sleep and breathing data at home for clinician review. Together they give providers ongoing data for early detection, treatment adjustments and follow-up on patient engagement.

Introduction

Sleep apnea disrupts the sleep of millions of people and puts their health at risk. Characterized by repeated interruptions in breathing during sleep, it causes fatigue and is linked to high blood pressure, heart disease, diabetes, and cognitive decline. Diagnosis has traditionally relied on an overnight stay at a sleep lab.

Impilo and Wesper are two health platforms that work together to support diagnosis and ongoing management. Impilo integrates a variety of medical devices for remote patient monitoring, and Wesper develops FDA-cleared home sleep testing medical devices used by clinicians.

Remote Patient Monitoring and Sleep Apnea

Remote Patient Monitoring (RPM) allows for continuous data collection outside of a clinical setting, giving healthcare providers a more complete picture of a patient’s sleep health. By tracking biometrics like oxygen saturation, respiratory patterns, heart rate, and sleep disturbances, RPM supports early detection, proactive intervention, and data-driven treatment adjustments.

RPM supports long-term monitoring in a patient’s own environment, which can give providers more representative data than a single night in a lab. Providers can use that data to follow how a patient responds to treatment over time.

Impilo: Remote Monitoring Through Device Integration

Designed with both clinicians and patients in mind, Impilo streamlines remote healthcare through simple integration with a variety of medical devices. Patients receive their devices and the support to use them, while providers receive real-time device data in their preferred platform. This supports data-driven decisions about patient care without burdening providers with additional workflows.

For sleep apnea patients, Impilo's device integration continuously collects and transmits important sleep-related health metrics, so providers can monitor progress, adjust treatments, and intervene when necessary between clinic visits.

Wesper: Home Sleep Testing

Wesper develops FDA-cleared home sleep testing medical devices used by clinicians. Wesper Lab uses two wearable patches on the chest and abdomen and measures airflow, thoracic and abdominal effort, body position, SpO2, heart rate and sleep staging, with no nasal cannula. Multi-night testing comes standard, and clinicians get full access to raw data for review. Wesper devices show over 95% AHI correlation to in-lab PSG (Sleep Medicine 2025; JCSM 2023).

Wesper Lab adds objective measurements to a patient’s reported symptoms, giving providers data to assess sleep quality and potential sleep apnea severity.

Impilo and Wesper Together

Combining Impilo’s real-time RPM capabilities with Wesper’s home sleep testing gives providers data they can use for both detection and ongoing management of sleep apnea.

Early Detection and Continuous Monitoring: Providers can begin following a patient’s sleep health at home, and continuous tracking can flag early signs of deterioration.

Personalized, Data-Driven Treatment Plans: With ongoing, real-world data from both platforms, healthcare providers can base treatment decisions, such as CPAP therapy settings or lifestyle recommendations, on longitudinal trends rather than a single night.

Patient Engagement and Adherence: Adherence to therapy is one of the biggest challenges in sleep apnea treatment. Giving patients access to their own sleep data can support a better understanding of their condition and may help them stay with therapy.

What This Means for Providers and Patients

Pairing Impilo’s RPM technology with Wesper’s home sleep testing gives clinicians ongoing data on how a patient sleeps and responds to therapy, and gives patients a more active role in their own care. Clinicians can learn more about Wesper on the Wesper provider page.

Frequently Asked Questions (FAQ)

1. What is sleep apnea, and why is it a serious health concern?

Sleep apnea is a condition where breathing repeatedly stops and starts during sleep, leading to poor oxygen flow to the brain and body. It’s associated with serious health risks, including high blood pressure, heart disease, diabetes, and cognitive decline. Left untreated, it can severely impact overall health and quality of life.

2. How is sleep apnea traditionally diagnosed?

Sleep apnea has traditionally been diagnosed with an overnight polysomnography (PSG) study at a sleep lab, where patients wear multiple sensors and technicians monitor the night. PSG is the gold standard, and home sleep testing ordered by a medical provider is another option.

3. How do Impilo and Wesper improve sleep apnea diagnosis and management?

Impilo’s Remote Patient Monitoring (RPM) technology and Wesper’s wireless at-home sleep testing let providers follow a patient’s sleep health from home. Providers can use that real-world data to adjust treatment over time.

4. What is Remote Patient Monitoring (RPM), and why is it beneficial for sleep apnea?

RPM allows for continuous health tracking outside of clinical settings, giving providers a picture of a patient’s sleep patterns over time. Providers can use that data to adjust treatment between visits.

5. How does Wesper's home sleep test work?

Wesper Lab uses two wearable patches on the chest and abdomen, with no nasal cannula. It measures airflow, thoracic and abdominal effort, body position, SpO2, heart rate and sleep staging, and the data goes to the clinician for review.

6. How does Impilo enhance sleep apnea management?

Impilo handles device integration and real-time data transmission, so patients receive their monitoring devices and providers can access and analyze the data in their preferred platform. Providers can use ongoing monitoring data to adjust treatment.

7. How does the integration of Impilo and Wesper benefit patients?

• Early Detection: Providers can begin following a patient’s sleep health at home.
• Personalized Treatment: Continuous, real-world data allows doctors to tailor treatment strategies based on long-term trends.
• Patient Engagement: Access to sleep data can encourage patients to take an active role in their treatment and stay with therapy.

8. Can this technology replace in-lab sleep studies entirely?

No. In-lab polysomnography is the gold standard and remains the right choice for some patients, including complex cases. Home sleep testing gives providers another option, and RPM adds continuous, real-world data between visits.

9. Is the data collected by Wesper and Impilo secure?

Yes. Both platforms prioritize data security and HIPAA compliance, and Wesper is SOC 2 Type 2 compliant.

10. How can I get started with Wesper and Impilo for sleep apnea monitoring?

A medical provider orders the Wesper test. If you suspect you have sleep apnea or need ongoing monitoring, talk with your doctor or sleep provider about home sleep testing and Impilo and Wesper’s integrated system. They can guide you through receiving and setting up your devices.